drugset

drugset / Trial / NCT04937530

RT001 in Patients With Progressive Supranuclear Palsy (PSP) PROGRESSIVE SUPRANUCLEAR PALSY

NCT04937530 ↗

Phase 2 Unknown 40 enrolled Biojiva LLC

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, placebo-controlled trial of RT001 in patients with PSP.

Timeline

Start: 2021-06-23
Primary completion: 2022-07-30
Completion: 2022-08-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	RT001	Protein / enzyme biologic	5.76 g	—

Indications